• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.拯救脓毒症运动：成年患者液体复苏和血管活性药物治疗研究重点
Crit Care Med. 2021 Apr 1;49(4):623-635. doi: 10.1097/CCM.0000000000004864.
2
The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients.拯救脓毒症运动：成年患者的液体复苏和血管活性药物治疗研究重点
Intensive Care Med Exp. 2021 Mar 1;9(1):10. doi: 10.1186/s40635-021-00369-9.
3
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动：严重脓毒症和脓毒性休克治疗国际指南：2008年版
Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41.
4
The Surviving Sepsis Campaign: Where have we been and where are we going?拯救脓毒症运动：我们曾身处何方，又将去往何处？
Cleve Clin J Med. 2015 Apr;82(4):237-44. doi: 10.3949/ccjm.82gr.15001.
5
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.拯救脓毒症运动：脓毒症和脓毒性休克的研究重点。
Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.
6
Surviving sepsis campaign: research priorities for sepsis and septic shock.拯救脓毒症运动：脓毒症和脓毒性休克的研究重点。
Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.
7
The Surviving Sepsis Campaign: Basic/Translational Science Research Priorities.拯救脓毒症运动：基础/转化科学研究重点。
Crit Care Med. 2020 Aug;48(8):1217-1232. doi: 10.1097/CCM.0000000000004408.
8
Initial resuscitation guided by the Surviving Sepsis Campaign recommendations and early echocardiographic assessment of hemodynamics in intensive care unit septic patients: a pilot study.以《拯救脓毒症运动》指南指导的初始复苏和重症监护室脓毒症患者血流动力学的早期超声心动图评估：一项初步研究。
Crit Care Med. 2012 Oct;40(10):2821-7. doi: 10.1097/CCM.0b013e31825bc565.
9
The surviving sepsis campaign: basic/translational science research priorities.拯救脓毒症运动：基础/转化科学研究重点
Intensive Care Med Exp. 2020 Jul 17;8(1):31. doi: 10.1186/s40635-020-00312-4.
10
From a pressure-guided to a perfusion-centered resuscitation strategy in septic shock: Critical literature review and illustrative case.从压力指导到灌注为中心的复苏策略在感染性休克中的应用：关键文献回顾和案例说明。
J Crit Care. 2020 Apr;56:294-304. doi: 10.1016/j.jcrc.2019.11.008. Epub 2020 Jan 8.

引用本文的文献

1
New insights in fluid monitoring for surgical patients. A concept study.手术患者液体监测的新见解。一项概念研究。
Front Med Technol. 2025 Jul 21;7:1619238. doi: 10.3389/fmedt.2025.1619238. eCollection 2025.
2
Impact of early haemodynamic assessment by echocardiography on organ dysfunction and outcome of patients admitted to the emergency department with sepsis or septic shock: protocol of a multicentre randomised controlled trial (GENESIS).超声心动图早期血流动力学评估对因脓毒症或脓毒性休克入住急诊科患者器官功能障碍及预后的影响：一项多中心随机对照试验（GENESIS）方案
BMJ Open. 2025 May 6;15(5):e098304. doi: 10.1136/bmjopen-2024-098304.
3
How much is too much?: A retrospective causal analysis of the 7-day fluid balance for septic critical care patients.多少才算过量？：对脓毒症重症监护患者7天液体平衡的回顾性因果分析。
Medicine (Baltimore). 2024 Dec 27;103(52):e40733. doi: 10.1097/MD.0000000000040733.
4
Impact of 30 mL/kg fluid resuscitation completed within one hour on elderly septic shock patient.1小时内完成30毫升/千克液体复苏对老年感染性休克患者的影响
Ann Med. 2025 Dec;57(1):2445778. doi: 10.1080/07853890.2024.2445778. Epub 2024 Dec 26.
5
The Global Burden of Sepsis and Septic Shock.脓毒症和感染性休克的全球负担
Epidemiologia (Basel). 2024 Jul 25;5(3):456-478. doi: 10.3390/epidemiologia5030032.
6
Apelin-13 administration allows for norepinephrine sparing in a rat model of cecal ligation and puncture-induced septic shock.在盲肠结扎和穿刺诱导的脓毒性休克大鼠模型中，给予Apelin-13可减少去甲肾上腺素的用量。
Intensive Care Med Exp. 2024 Aug 5;12(1):68. doi: 10.1186/s40635-024-00650-7.
7
Focused Cardiac Ultrasound Findings of Fluid Tolerance and Fluid Resuscitation in Septic Shock.脓毒性休克中液体耐受性和液体复苏的心脏聚焦超声检查结果
Crit Care Explor. 2023 Dec 1;5(12):e1015. doi: 10.1097/CCE.0000000000001015. eCollection 2023 Dec.
8
The Effects of Heparan Sulfate Infusion on Endothelial and Organ Injury in a Rat Pneumosepsis Model.硫酸乙酰肝素输注对大鼠肺炎性脓毒症模型中内皮细胞及器官损伤的影响
J Clin Med. 2023 Oct 10;12(20):6438. doi: 10.3390/jcm12206438.
9
Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.优化脓毒性休克中血管加压素的使用和起始时机：一项叙述性综述。
Chest. 2023 Nov;164(5):1216-1227. doi: 10.1016/j.chest.2023.07.009. Epub 2023 Jul 20.
10
Evaluation of the Recommended 30 cc/kg Fluid Dose for Patients With Septic Shock and Hypoperfusion With Lactate Greater Than 4 mmol/L.对脓毒性休克且乳酸水平大于4 mmol/L伴有灌注不足患者推荐的30 cc/kg液体剂量的评估。
Crit Care Explor. 2023 Jul 13;5(7):e0932. doi: 10.1097/CCE.0000000000000932. eCollection 2023 Jul.

本文引用的文献

1
Resuscitation Guided by Volume Responsiveness Does Not Reduce Mortality in Sepsis: A Meta-Analysis.容量反应性指导下的复苏不能降低脓毒症死亡率：一项荟萃分析。
Crit Care Explor. 2019 May 23;1(5):e0015. doi: 10.1097/CCE.0000000000000015. eCollection 2019 May.
2
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.降低血管升压药暴露对老年血管舒张性低血压危重症患者90天死亡率的影响：一项随机临床试验
JAMA. 2020 Mar 10;323(10):938-949. doi: 10.1001/jama.2020.0930.
3
Lower vs Higher Fluid Volumes During Initial Management of Sepsis: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.低容量与高容量液体复苏治疗脓毒症的初始阶段：系统评价、Meta 分析与序贯试验分析。
Chest. 2020 Jun;157(6):1478-1496. doi: 10.1016/j.chest.2019.11.050. Epub 2020 Jan 23.
4
Association Between Volume of Fluid Resuscitation and Intubation in High-Risk Patients With Sepsis, Heart Failure, End-Stage Renal Disease, and Cirrhosis.容量复苏与高危患者脓毒症、心力衰竭、终末期肾病和肝硬化患者插管的关系。
Chest. 2020 Feb;157(2):286-292. doi: 10.1016/j.chest.2019.09.029. Epub 2019 Oct 14.
5
154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial.与成人胸部大手术（TOPMAST）患者静脉维持液治疗中 54mmol/L 的钠相比，154mmol/L 的钠：一项单中心随机对照双盲试验。
Intensive Care Med. 2019 Oct;45(10):1422-1432. doi: 10.1007/s00134-019-05772-1. Epub 2019 Oct 1.
6
Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.以外周灌注状态为目标的复苏策略与脓毒性休克患者血清乳酸水平的影响。ANDROMEDA-SHOCK 试验的贝叶斯再分析。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):423-429. doi: 10.1164/rccm.201905-0968OC.
7
Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.脓毒症患者中平衡晶体液与生理盐水的比较： SMART 临床试验的二次分析。
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1487-1495. doi: 10.1164/rccm.201903-0557OC.
8
Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis.平衡晶体液与生理盐水在危重症成人中的比较：系统评价和荟萃分析。
Ann Pharmacother. 2020 Jan;54(1):5-13. doi: 10.1177/1060028019866420. Epub 2019 Jul 31.
9
Lactated Ringer's Versus 4% Albumin on Lactated Ringer's in Early Sepsis Therapy in Cancer Patients: A Pilot Single-Center Randomized Trial.乳酸林格氏液与白蛋白联合乳酸林格氏液在癌症患者早期脓毒症治疗中的比较：一项单中心随机试验的初步研究。
Crit Care Med. 2019 Oct;47(10):e798-e805. doi: 10.1097/CCM.0000000000003900.
10
Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children.用于重症成人和儿童复苏的缓冲溶液与0.9%生理盐水的比较。
Cochrane Database Syst Rev. 2019 Jul 19;7(7):CD012247. doi: 10.1002/14651858.CD012247.pub2.

拯救脓毒症运动：成年患者液体复苏和血管活性药物治疗研究重点

The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.

作者信息

Lat Ishaq, Coopersmith Craig M, De Backer Daniel

机构信息

Department of Pharmacy, Shirley Ryan AbilityLab, Chicago, IL.

Department of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA.

出版信息

Crit Care Med. 2021 Apr 1;49(4):623-635. doi: 10.1097/CCM.0000000000004864.

DOI:10.1097/CCM.0000000000004864
PMID:33731607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7963440/
Abstract

OBJECTIVE

Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.

DATA SOURCES

Original article, literature search.

STUDY SELECTION

Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.

DATA EXTRACTION

None.

DATA SYNTHESIS

None.

CONCLUSION

In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.

摘要

目的

详细阐述由危重病医学会和欧洲重症监护医学会指定的一组专家确定的液体复苏和血管加压药治疗研究重点的优先事项。

数据来源

原始文章、文献检索。

研究选择

原始特别工作组中几位在液体复苏和血管加压药治疗领域具有特定专业知识的成员。

数据提取

无。

数据综合

无。

结论

在原始文章之后的一系列手稿中的第二篇，该主题的专家成员详细阐述了与液体复苏和血管加压药治疗相关的三个确定的优先事项。本分析总结了已知内容以及确定为正在进行和未来的研究。